News About: Pharm. Industry
Unilateral move to slash drug prices provokes protest
The government's move to cut drug prices has provoked criticism from the heads of 10 pharmaceutical organizations, including the Korea Pharmaceutical Manufacturers Association, the Korea Research based Pharmaceutical ...
Bayer Korea supplies contraceptives with wrong expiration date
Bayer Korea has been criticized for supply of its contraceptive Meliane tablets with incorrect labeling of expiration date.
As shown in the photo, the shelf life of Meliane tablets is erroneously described on the s...
Corporate margin thinner in first half
Korean pharmaceutical companies have seen their profit margins worsening in the first half of this year due to uncertain business climates and fiercer competition.
A total of 32 drug firms listed on the main bourse...
Smaller profit margin of multinational firms corners domestic wholesalers
Just as the pharmaceutical industry is feeling price and margin pressure, so are wholesalers in today’s healthcare marketplace.
There are also growing concerns over the thinner profit margin of multinational compan...
Plans to cut generic drug prices may cause fiasco in pharmacies
The government on August 12 unveiled a set of plans to cut generic drug prices by up to 33 percent starting next year, prompting fierce protests from pharmaceutical companies.
The new measures will bring down the p...
Korea urged to cut drug prices
Korea should carry out its ongoing reforms to address its disproportionately high expenditure on pharmaceuticals, despite universal health insurance.
An ad-hoc committee, set up in April by the Ministry of Health a...
Korean drugmakers protest against relentless price cuts
The Korea Pharmaceutical Manufacturers Association has vehemently protested against the government’s new price cuts.
In a second statement issued on Tuesday, the KPMA said that although the government is seeking to...
Pharma related industries likely to fall victim to hard times
A variety of industries relating to pharmaceutical facility and equipment, raw materials and printing are taking a direct hit from the latest government’s plan to cut drug prices as pharmaceutical firms are moving to ...
M&As, restructuring to sweep pharmaceutical industry
The government’s plan to cut prices for drugs covered by health insurance by an average of 17 percent will make it harder for companies to do business.
Analysts expect a large number of mergers and acquisitions (M&...
Will Kwangdong’s Vita 500 revenue be affected by new Bacchus F?
Dong-A Pharmaceutical announced on August 22 that it would revive the production of Bacchus-F - discontinued in 2005 - by reopening its shuttered factory in Daegu and supplying the product directly to non-pharmacy ret...
